Immune Regulation in Multiple Sclerosis: MicroRNA and Antigen-Presenting Cells
Phase of Trial: Phase IV
Latest Information Update: 19 Nov 2013
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 24 Apr 2013 Primary endpoint added as reported by ClinicalTrials.gov.
- 01 Jan 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 May 2012 New trial record